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ABSTRACT
Fibroblast growth factor receptor 3 (FGFR3) plays an
important role in cartilage development. Although
upregulation of FGFR3 expression in response to
bone morphogenetic protein-2 (BMP-2) has been
reported, the molecular mechanisms remain
unknown. In this study, we used in vivo approaches
to characterize BMP-2-induced alterations in the
chromatin organization of the FGFR3 core promoter.
Chromatin immunoprecipitation analysis demon-
strated that the binding of Brg1, a component of
the SWI/SNF remodeling complex, may selectively
remodel a chromatin region (encompassing nucleo-
tide –90 to +35), uncovering the transcription start
site and three Sp1-binding sites, as revealed by
nuclease digestion hypersensitivity assays. We
then showed an increase in the association of Sp1
with the proximal promoter, followed by the recruit-
ment of p300, resulting in a change of the histone
‘code’, such as in phosphorylation and methylation.
Collectively, our study results suggest a model
for BMP-2-induced FGFR3 expression in which
the core promoter architecture is specifically
regulated.
INTRODUCTION
Growth factors that have been implicated in chondro-
genesis include ﬁbroblast growth factors (FGFs),
platelet-derived growth factor, bone morphogenetic
proteins (BMPs) and transforming growth factor.
Fibroblast growth factor receptors (FGFRs) constitute a
family of four members with tyrosine kinase activity;
among these, FGFR3 plays an important role in cartilage
development. Three inherited human dwarﬁsm syn-
dromes—hypochondroplasia, achondroplasia and thana-
tophoric dysplasia—are caused by missense mutations in
the FGFR3 gene. These mutations lead to diﬀerent levels
of receptor activation, which correlate well with the sever-
ity of the human phenotypes (1).
FGFR3 has been identiﬁed in the cartilage primordia
of developing mouse long bones. Several mouse models
mimicking the human achondroplasia phenotype have
been created by expressing mutated forms of FGFR3 in
the developing cartilage anlagen (2–4). These mice display
a severe shortening of the appendicular skeletal elements
due to reduced regions of proliferating and hypertrophic
chondrocytes. Additionally, mice carrying a targeted dele-
tion of FGFR3 are characterized by increased regions
of proliferating and hypertrophic chondrocytes (5,6).
These studies have led to the conclusion that FGF signal-
ing is a negative regulator of chondrocyte proliferation
and diﬀerentiation.
Interestingly, evidence from other reports indicates
a role for FGFR3 signaling in promoting chondrocyte
diﬀerentiation. For example, FGF18 has been identiﬁed
as a selective ligand for FGFR3 in mouse limb bud
mesenchymal cells, which suppressed proliferation and
promoted their diﬀerentiation and production of the car-
tilage matrix (7). These observations support those from
in vivo studies of the growth plates of human thanatopho-
ric dwarfs (8) and the results of in vitro studies of human
articular chondrocytes (9), as well as those of transgenic
mice expressing constitutively active FGFR3 in the artic-
ular joints (10) and examinations of mouse limb explants
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BMPs are present in the mesenchyme and are necessary
for aggregation of mesenchymal cells and maturation of
chondrocytes in vivo (12). BMPs signiﬁcantly induce chon-
drocyte diﬀerentiation and promote the expression of car-
tilage-speciﬁc genes in primary cultures of chondrocytes,
as well as in cell lines such as ATDC5 and C3H10T1/2
(13–15). In a previous study, the BMP-2-dependent onset
of chondrogenic diﬀerentiation in the pluripotent murine
mesenchymal stem cell line (C3H10T1/2) was reported
to be accompanied by the immediate upregulation of
FGFR3 (16). Overexpression of FGFR3 in C3H10T1/2
cells is suﬃcient for chondrogenic diﬀerentiation, indicat-
ing an important role for FGF signaling during the man-
ifestation of the chondrogenic lineage in this cell line.
Despite extensive studies of FGFR3, the transcription
factors that interact with the FGFR3 promoter in the
process of chondrogenesis have yet to be identiﬁed and
functionally characterized. As previously reported, the
sequence between –220 and –27bp (upstream of the
transcription start site) of the FGFR3 gene, conferred a
20–40-fold increase in transcriptional activity upon a pro-
moter-less vector (17), and may serve as the core pro-
moter. In this study, we examined the order of events
occurring on the core FGFR3 promoter in vivo during
BMP-2-dependent transcriptional activation, using nucle-
ase digestion assays and chromatin immunoprecipitations
(ChIP). Following BMP-2 induction, the remodeling
complex SWI/SNF is assembled on the proximal pro-
moter and functions by targeting a speciﬁcally positioned
nucleosome (Nuc +1) that masks the start site of tran-
scription and Sp1-binding sites. We also revealed a cas-
cade of molecular recruitment events following assembly
of the remodeling complex, beginning with Sp1 binding to
the promoter, followed immediately by p300 recruitment,
resulting in an alteration in modiﬁcation of the histone
tail, which suggests that BMP-2 upregulates FGFR3
expression through controlling the core promoter
structure.
MATERIALS AND METHODS
Materials
C3H10T1/2 cells were purchased from American Type
Culture Collection (ATCC, Manassas, VA) and main-
tained in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
with 10% fetal bovine serum (FBS), 100units/ml penicil-
lin, and 100mg/ml streptomycin. Antibodies were pur-
chased from the following companies: Sp1 (SC-59G),
p300 (SC-584), Brg1 (SC-10768) and RNA polymerase
II (SC-9001) from Santa Cruz (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA); tetra-
acetyl-H4 (06-866) and diacetyl-H3 (07-593) from
Upstate (Charlottesville, VA, USA); dimethyl-H3-K9
(7312) and trimethyl-H3-K4 (8580) from Abcam
(Abcam, Inc., Cambridge, MA, USA); p38MAPK
(9212) and phospho-p38 (9215) from Cell Signaling
Technology (Cell Signaling Technology, Inc., Boston,
MA, USA); p38 inhibitor SB203580 was purchased
from Calbiochem (Calbiochem Inc., San Diego, CA,
USA); cycloheximide (CHX) was obtained from Sigma
(Sigma-Aldrich, St Louis, MO, USA) and BMP-2 was
from R&D systems (R&D Systems, Inc., Minneapolis,
MN, USA).
Cell culture
To examine the eﬀects of BMP-2 on FGFR3 expression,
C3H10T1/2 cells were incubated for 1day with indicated
amount of BMP-2 or cells were incubated in the presence
or absence of 200ng/ml BMP-2 for indicated period of
time, in the medium with 5% FBS. Pre-incubation with
10-mM CHX (inhibitor of protein synthesis) or 10mM
SB203580 (blocking the p38 MAPK pathway) was per-
formed for 30min, followed by the addition of BMP-2
and further incubation for 1day in the continued presence
of CHX or SB203580 (18,19).
Reverse transcription PCR (RT–PCR)
Total RNA was extracted and puriﬁed using an RNeasy
Kit (Qiagen, Inc., Valencia, CA, USA). Reaction mixture
(25ml) containing 2mg of total RNA was reverse tran-
scribed to cDNA using SuperScript II RT-polymerase
(Invitrogen Corp., Carlsbad, CA, USA). PCR was per-
formed on the cDNA using primers speciﬁc for FGFR3
(50-ttggcatgcggtgccttcac-30 and 50-gaggtccaagtactcgtcgg-30)
and 18s rRNA (50-cctggataccgcagctagga-30and 50-gcggcgca
atacgaatg cccc-30). The PCR reaction mix for quantitative
RT–PCR (qRT–PCR) was prepared using SYBR Green
PCR Master Mix (Applied Biosystems, Foster City, CA,
USA), and the PCR conditions for quantitative RT-PCR
were as follows: activation of enzyme at 958C for 5min, 45
cycles of denaturation at 958C for 15s, annealing at 578C
for 5s, and extension at 728C for 25s. qRT–PCR was
carried out using a 7300 Real Time PCR System
(Applied Biosystems). The ﬂuorescence of each sample
was determined after every cycle, and denaturation
curves of the PCR products were determined by increasing
the temperature at the rate of 0.18C/min from 558Ct o
958C. The ﬂuorescence of samples was continuously
traced during this period. All the melting curves of PCR
products gave a single peak. Agarose gel electrophoresis of
representative reactions was used to conﬁrm the ampliﬁ-
cation of unique fragments of predicted lengths. Relative
FGFR3 expression levels were calculated as ratios of
FGFR3 mRNA levels normalized against those of 18s
rRNA. The data from qRT–PCR were analyzed by the
Ct method, and the Ct value was determined by
subtracting the 18s rRNA Ct value from the target gene
Ct value. The Ct of the stimulated cells (Cts) was sub-
tracted from the Ct of the untreated cells (Ctu)
(Ct=Cts – Ctu), and the expression level for a
target gene in the stimulated cells compared with
the level in the untreated cells was calculated as fol-
lows: x-fold of unstimulated control=2
 Ct. All results
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Nuclease hypersensitivity assays
In brief, nuclear pellets were resuspended in 3ml of buﬀer
A (10mM Tris [tris (hydroxymethyl) aminomethane], pH
7.4, 10mM NaCl, 3mM MgCl2, 0.3M sucrose). Aliquots
of nuclei were digested with increasing concentrations of
DNase I (0, 1, 3, 5U/ml) (Worthington Biochemical
Corp., Freehold, NJ, USA) in a 400-ml ﬁnal volume of
buﬀer A with 1mM CaCl2 for 5min at room temperature.
The reaction was stopped by adding 400ml of Stop buﬀer
(50mM Tris–HCl [pH 7.5], 150mM NaCl, 50mM EDTA,
0.3% sodium dodecyl sulfate [SDS]) and incubated with
10 U of RNase at 378C for 1h. The samples were extracted
once with phenol–chloroform–isoamyl alcohol (25:24:1)
and once with chloroform–isoamyl alcohol (24:1).
Nucleic acids were precipitated with 0.7 volumes of iso-
propanol, washed with 70% ethanol and resuspended in
1  TE buﬀer (10mM Tris–HCl [pH 7.5], 1mM EDTA).
Sensitivity to micrococcal nuclease (MNase) was deter-
mined using a freshly prepared suspension of nuclei in
MNase digestion buﬀer (15mM Tris–HCl [pH 7.5],
60mM KCl, 15mM NaCl, 1mM CaCl2, 3mM MgCl2,
20% glycerol, 15mM 2-mercaptoethanol). DNA concen-
trations were estimated by absorption at 260nm. Equal
amounts of nuclei were digested with increasing concen-
trations of MNase I (0, 0.2, 0.4, 0.6U/ml) (Worthington
Biochemical Corp., Lakewood, N.J., USA) in a 400ml
ﬁnal volume for 5min at 208C. The reactions were then
stopped, and DNA was extracted as described above.
For the restriction enzyme accessibility assays, nuclei
were isolated as described above and digested with
25–150U of restriction enzyme in 300ml of the corre-
sponding reaction buﬀer (New England Biolabs, Beverly,
MA, USA) for 30min at 378C. Reactions were terminated,
and DNA was extracted as described above. After puriﬁ-
cation, DNA (15mg) was digested to completion with
Hind III or Nco I. The products were resolved on agarose
gel and detected by Southern blotting using the indirect
end-labeling method.
Analysis of chromatin by indirect end labeling
Southern blotting was performed essentially as previously
described (20). DNA (15mg) was digested to completion
with Hind III or Nco I, then electrophoresed in 0.8% or
1.5% agarose gel in 1  TAE buﬀer (40mM Tris–acetate,
1mM EDTA; pH 8.0). The digested DNA was then trans-
ferred to Hybond N+ membrane and FGFR3 gene frag-
ments were detected by hybridization with radioactive
probes obtained by random priming. The following
primer sets were used to amplify probes anchored at
Hind III or Nco I sites: HindIII-F, 50-GAATTCTCCGA
TGGGACACTTGAATG-30; HindIII-R, 50-TCTAGACC
CAGGTTAATGAACCACTG-30; NcoI-F, 50-GAATTC
GAACCCAGGACTGGATTCTA-30; NcoI-R, 50-TCTA
GAGGACTACCATGGCTCCAGAG-30. After double
digestion with EcoR I and Xba I, the PCR products
were cloned into pUC19. Both probes were extracted
from agarose gel after restriction enzyme digestion of
plasmid pUC19 DNA by EcoR I and Xba I for puriﬁca-
tion; the probes were then labeled with
32P by random
priming. Prehybridization and hybridization were per-
formed at 658C, using 5  SSC (10  SSC is 1.5M NaCl,
0.15M sodium citrate; pH 7.4), 0.7% SDS, and
5  Denhardt solution (0.1% Ficoll, 0.1% polyvinylpyrro-
lidone, 0.1% bovine serum albumin), followed by three
sequential washes under stringent conditions. The intensi-
ties of the bands were determined using a molecular
imager System (Bio-Rad Laboratories, Inc., Hercules,
CA, USA), and the percentage of digestion was quantiﬁed
as the fraction of the signal of the band compared with the
total signal of the bands within a given lane on the gel.
Size markers were generated by ampliﬁcation of a series of
100bp DNA ladders with a ﬁxed 50 end, using plasmid
pcDNA3.1 as a template. PCR products were mixed
together and electrophoresed with the nuclear samples,
then transferred and hybridized with [
32P]dATP-radiola-
beled probes spanning the ladders.
ChIPs and Re-ChIPs
Cells were incubated in 1% formaldehyde for 10min at
228C and the reaction then stopped by addition of glycine
to a ﬁnal concentration of 0.125M. The cells were then
washed with cold phosphate-buﬀered saline and lysed in
buﬀer. Nuclei were sonicated to shear DNA, and the
lysates were pelleted and precleared. Sonicated chromatin
was incubated with 4mg of antibodies. The protein–DNA
complexes were incubated with protein A beads and eluted
in 1% SDS/0.1M NaHCO3 and cross-links were reversed
at 658C. DNA was recovered by phenol–chloroform
extraction and ethanol precipitation, then subjected to
semi-quantitative PCR analysis. In the Re-ChIP experi-
ments, complexes were eluted by incubation for 30min
at 378C in 25ml 10mM DTT. After centrifugation, the
supernatant was diluted 20 times with Re-ChIP buﬀer
(1% Triton X-100, 2mM EDTA, 150mM NaCl, 20mM
Tris–HCl, [pH 8.1]) and subjected again to the ChIP
procedure.
Real-time PCR reactions were performed in triplicate
with 2ml of precipitated DNA. DNA recovered from
samples containing an antibody was compared with no-
antibody negative controls performed on aliquots from
the same chromatin preparation. Additionally, uniformity
of the chromatin preparations was conﬁrmed by analyzing
the background level of an unrelated genomic locus by
real-time PCR. Data are presented as the amount of
DNA recovered relative to the appropriate negative con-
trol antibody. In this way, diﬀerences between chromatin
preparations are normalized. The results were expressed as
the means standard deviations of three independent
experiments. The PCR primers were as follows: –3k
region (Forward: 50-GCCTTTACATAGATAGAGTG-
30; Reverse: 50-TGTACCGTGTGCTTCTAGAC-30); +1
region (Forward: 50-AGCTCGGCATTGCTTCAAG-30;
Reverse: 50-TGCCACAGTGCACTGAACT-30); +6k
(Forward: 50-GTTCCAGGGCCTGAACCTAG-30;
Reverse: 50-TAGCACTTGCAGCCTCTGAG-30);
30UTR (Forward: 50-GCTTAACACTTCCTATGCAG-
30; Reverse: 50-AAACCACATCTGCCAGTGTG-30).
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Plasmid DNA was transiently transfected into C3H10T1/
2 cells using Lipofectamine 2000 (Invitrogen Corp.).
phRL-TK (Promega, Madison, WI, USA) was co-trans-
fected as an internal control for transfection eﬃciency.
After further cultivation under serum-deprived conditions
for 24h, the transfected cells were harvested, lysed, cen-
trifuged and the pellet subjected to luciferase assay.
Luciferase activity was measured as chemiluminescence
in a luminometer (PerkinElmer Life Sciences, Boston,
MA, USA) using the Dual-Luciferase Reporter Assay
System (Promega) according to the manufacturer’s proto-
col. All transfections were performed in triplicate, and the
results were expressed as the means standard deviations
of three independent experiments.
Construction of reporter plasmids and mutagenes
PCR was performed using a pair of oligonucleotide prim-
ers (Forward: 50-ATGCCTTTACATA GATAGAGT
G-30; Reverse: 50-ATGGTACCATCTCGAGTGTACCG
TGTGCTTCTAGAC-30) speciﬁc for the mouse FGFR3
promoter corresponding to the –224/+15 fragment, of
which the forward primer was Kpn I-site-linked and
the reverse primer Xho I-site-linked. C3H10T1/2 genomic
DNA was used as the template. These PCR products
were digested with Kpn I and Xho I, and subcloned
into the Kpn I/Xho I sites of the pGL3 Basic vector
(Promega), yielding the reporter plasmid pGLP.
Substitution mutation constructs were generated using a
PCR-based site-directed mutagenesis kit (TaKaRa Co.
Ltd., Tokyo, Japan), using the pGLP plasmid as the tem-
plate. For six-base substitutions, we introduced the EcoR
I restriction site GAATTC into the substitution sites. Oli-
gonucleotides containing three repeats of BMP-2 respon-
sive element (3  GCCGCGCCGGCTCCAGGGCAGG
AGCGGC) were synthesized and inserted into the pGL3
promoter vector (Promega) after digestion with Kpn I and
Xho I, yielding the positive reporter pGL3BMRE.
Statistical analysis
Statistical evaluations were conducted using the t-test.
P-values <0.05 were considered to be statistically
signiﬁcant.
RESULTS
BMP-2 stimulates FGFR-3 expression in C3H10T1/2 cells
through the p38 pathway independent of protein synthesis
The eﬀect of BMP-2 on the FGFR-3 mRNA expression
level in C3H10T1/2 was determined by quantitative
RT-PCR. As shown in Figure 1A, FGFR-3 expression
was dose-dependently induced by 10–200ng/ml of BMP-
2. FGFR-3 mRNA induction appeared as early as 30min
following BMP-2 stimulation, reached a high level at 1h,
then continued to increase slowly (Figure 1B). To deter-
mine whether protein synthesis was required for BMP-2
Figure 1. Upregulation of FGFR3 expression by BMP-2 treatment in C3H10T1/2 cells. (A, B) C3H10T1/2 cells were incubated with the indicated
dosage of BMP-2 with 5% FBS for 1day (A), or for the indicated periods of time in the presence of 200ng/ml BMP-2 with 5% FBS (B) and total
RNA was extracted for measurement of FGFR3 mRNA expression level by semi-quantitative RT–PCR.  P<0.05;   P<0.01 versus the correspond-
ing untreated cells. All the results are the means of three independent experiments   standard deviation. (C) C3H10T1/2 cells were pretreated with
control or SB203580 (10mM) for 30min and cultured for another 30min in the presence or absence of BMP-2 (200ng/ml). The whole lysates were
examined by immunoblotting with antibodies against phosphorylated p38 and total p38. (D) C3H10T1/2 cells were pretreated with SB203580
(10mM) or CHX (10mM) for 30min, followed by addition of BMP-2 (200ng/ml) for 1day in the continued presence of CHX or SB203580.
FGFR3 mRNA expression level was examined by semi-quantitative RT–PCR. The PCR products were electrophoresed on agarose gel and stained
with ethidium bromide.
3900 Nucleic Acids Research, 2009, Vol. 37,No. 12induced FGFR3 expression, CHX, a protein synthesis
inhibitor, was applied. Pretreatment with CHX did not
inhibit the BMP-2-induced increase in FGFR3 expression
as analyzed by qRT–PCR analysis (Figure 1D, lane 2
versus lane 4), suggesting that the upregulation of
FGFR3 expression is independent of protein synthesis
in C3H10T1/2 cells.
In a previous study, it was determined that the BMP-2/
Smads pathway was not responsible for immediate stimu-
lation of FGFR3 expression (16). Another pathway that
may play a role in FGFR3 expression is the BMP/p38
pathway. The importance of the BMP/p38 pathway was
examined by pretreatment of C3H10T1/2 cells with
SB203580, a speciﬁc inhibitor of p38 kinase. Pre-incuba-
tion of 10mM SB203580 for 30min partially blocked
BMP-2-induced p38 phosphorylation (Figure 1C) and
greatly inhibited the increase in FGFR3 expression
elicited by BMP-2 (Figure 1D, lane 2 versus lane 3).
Together, these data suggest that the p38 kinase pathway
contributes to BMP2-mediated immediate upregulation
of FGFR3 expression in C3H10T1/2 cells.
Open chromatin structure around the transcription start site
It is generally accepted that the local chromatin structure
aﬀects gene transcription. We performed DNase I hyper-
sensitivity assays in an attempt to reveal regions of open
chromatin around the FGFR3 gene promoter upon
BMP-2 exposure, in order to provide cues in the search
for the regulation sites of BMP-2 signaling at the promoter
level. In these experiments, C3H10T1/2 cells were either
left untreated or treated with BMP-2 for 1day. Nuclei
were isolated and subjected to digestion with increasing
concentrations of DNase I, and the genomic fragments
between –10374bp and +2540bp (relative to the tran-
scription start site) were analyzed. As shown in Figure 2,
in untreated conditions, a band gradually appeared in a
DNase I concentration-dependent manner, representing a
single DNase I hypersensitive site (DHS) that was adjacent
to the transcription start site of the FGFR3 promoter and
 2.7kb upstream of the Hind III site at +2540bp.
Importantly, on stimulation with BMP-2 (200ng/ml), the
hypersensitive band appeared wider than that of the
untreated cells; thus, after screening a large range of
 13kb around the transcription start site, we found a
single DNaseIhypersensitive siteinthe proximal promoter
region,whichwasassociatedwithboththebasalandBMP-
induced transcription of FGFR3 in C3H10T1/2 cells.
Additionally, we performed control digestion of naked
genomic DNA in vitro with increasing concentrations
of DNase I. No preferential cutting was observed in con-
ditions that generated levels of digestion comparable to
those obtained in the in vivo experiments, conﬁrming
that the DNase I hypersensitivity observed was a conse-
quence of chromatin organization and not secondary to
sequence-directed cleavage preference by DNase I.
BMP-2-induced nucleosome remodeling at the proximal
promoter of the FGFR3 gene
We next sought to map the hypersensitive site more pre-
cisely and to determine the nucleosomal organization
within the FGFR3 proximal promoter region. MNase pre-
ferentially digests nucleosome-free DNA and linker DNA,
and can therefore be used to determine nucleosome remo-
deling. Digestion of a nucleosomal array using limited
amounts of MNase produces a ladder of DNA fragments
corresponding to multiples of the nucleosome particle
( 160bp). Nuclei were isolated from C3H10T1/2 cells
and digested with increasing amounts of MNase.
A discrete band pattern (Figure 3A) was revealed in
untreated C3H10T1/2 cells. The overall digestion pattern
indicated a pattern consistent with precise nucleosome
positioning. Particularly, in untreated cells we detected a
strong and speciﬁc band  1kb from the Nco I site, at
  200bp relative to the transcription start site. Bmp-2
treatment did not alter the whole band pattern, and the
signal of the major band at –200bp did not change as
compared with that of untreated cells with the same
amount of MNase. However, the 30 boundary extended
further into the next linker region in BMP-2-treated
cells, which indicated that the major band in untreated
cells correlates with the basal transcription of FGFR3,
and the neighboring nucleosome may be removed from
the local region in response to BMP-2 treatment.
In order to conﬁrm the relationship between the MNase
hypersensitive site (the major band at –200bp) and the
Figure 2. Inducible DNase I hypersensitivity within the FGFR3 pro-
moter. (A) Schematic representation of the probe used to map the
DNase-hypersensitive sites within the FGFR3 promoter by the indirect
end-labeling technique. (B) C3H10T1/2 cells were treated with or with-
out 200ng/ml BMP-2 with 5% FBS for 1day. Nuclei were then puri-
ﬁed and digested with increasing concentrations of DNase I (0, 1, 3,
5U/ml). DNA was puriﬁed and cleaved with Hind III. After Southern
blotting, the ﬁlter was hybridized with the
32P-labeled probe. The
DNase I-hypersensitive sites are indicated by arrowheads. As a control,
puriﬁed genomic DNA from C3H10T1/2 cells was digested in vitro with
increasing concentrations of DNase I (0, 0.05, 0.1, 0.2U/ml).
Nucleic Acids Research, 2009,Vol.37, No. 12 3901DNase I hypersensitive site, we performed the DHS assay
again using the same restriction enzyme, Nco I, for DNA
digestion and the same probe for Southern blot as in the
MNase digestion experiment. As shown in Figure 4, there
is a remarkable congruence in the positions of the DNase I
and MNase hypersensitive sites in the proximal promoter.
Interestingly, the range of the DHS may be expanded by
BMP-2 addition, suggesting that the region immediately
downstream of the DHS is resistant to nuclease digestion
under basal conditions, but becomes sensitive to nuclease
after stimulation with BMP-2.
To analyze more precisely the locations and boundaries
of these chromatin changes, a restriction enzyme accessi-
bility assay was employed. Nuclei isolated from BMP-
2-treated or untreated C3H10T1/2 cells were subjected
to limited digestion with a panel of restriction enzymes
with recognition sites at diﬀerent locations around the
nuclease hypersensitive site (NHS). As shown in
Figure 5, under basal conditions, restriction sites of Hinc
II/–287, Acc I/ 237, BstY I/ 109, Sma I/ 37, ApaL I/ 3
and BceA I/+35 were resistant to nuclease digestion, indi-
cating their coverage by nucleosomes. In contrast, stron-
ger cleavage was detected for Taq I/ 202, Eci I/ 174, Ear
I/ 115 and Bsa I/+95, suggesting that these sites were in
two linker regions, with greater accessibility to restriction
enzymes. BMP-2-dependent restriction enzyme cleavages
were apparent when the nuclei were incubated with BstY
I, Sma I, ApaL I and BceA I (Figure 5B); in contrast,
BMP-2-induced cleavages were not observed for other
restriction sites, including Taq I/ 202, Eci I/ 174 and
Ear I/ 115 (Figure 5B). These results suggest that the
region in which BMP-2-induced changes in chromatin
structure take place extends from at least  109bp (BstY
I site) to at least +35bp (BceA I site). Because digestion
with enzymes cutting just upstream (Ear I/ 115) and
downstream (Bsa I/+95) of the region remain unchanged
upon BMP-2 exposure, we more precisely mapped the
boundaries of the region undergoing chromatin remodel-
ing on BMP-2 induction to between nt  115 and  109 in
50 and nt +35 and +95 in 30. The size of this region, which
ranges from 144 to 210bp, corresponds to the length of
DNA protected by a nucleosome, suggesting the selective
remodeling of this nucleosome on FGFR3 transcriptional
activation.
Among the restriction enzymes applied in our experi-
ments, Sma I and BceA I are sensitive to DNA methyla-
tion, however the proximal promoter DNA of FGFR3 is
hypomethylated even in untreated cells while the level of
the basal FGFR3 transcription (shown in Figure 1D) indi-
cated the relative active state of the FGFR3 promoter in
the absence of BMP-2 treatment.
Based on the chromatin structure analysis of the
FGFR3 promoter region by means of DNase I, MNase
and restriction enzyme studies, we established a tentative
map of positioned nucleosomes within the FGFR3
regulatory regions (Figure 5, bottom panel). Although
the low-resolution methods used in our study do not pin-
point nucleosome positions on the nucleotide, the results
Figure 3. Mapping of the nucleosomes within the FGFR3 promoter upon BMP-2 treatment. C3H10T1/2 cells were either incubated with medium
alone or stimulated with BMP-2 (200ng/ml) with 5% FBS for 24h. Nuclei were then puriﬁed and digested with increasing concentrations of MNase
(0, 0.2, 0.4, 0.6U/ml). The major MNase hypersensitive sites (MHSs) are indicated by the solid arrowheads; other MNase cutting sites are marked by
hollow arrowheads. Increase in MNase hypersensitivity on BMP-2 stimulation is indicated by an extension of the hypersensitive site. As a control,
puriﬁed genomic DNA from C3H10T1/2 cells was digested in vitro with increasing concentrations of MNase. Size markers were generated as
described in ‘Material and Methods’ section. The diagrams at the right of each panel indicate the positions of putative nucleosomes (circles and
ovals) and the probes used for hybridization (solid bars); the arrows indicate the transcription start site.
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the core promoter. In untreated cells, the nuclease hyper-
sensitive site is located in a histone-free region between
two nucleosomes (Nuc+1 and Nuc–1). Upon BMP-2
treatment, the nucleosome (Nuc+1) just downstream of
the nuclease hypersensitive site is removed, resulting in a
promoter region with greater accessibility. Thus, we sup-
pose that the remodeling of the nucleosome may contrib-
ute to BMP-2-induced FGFR3 expression.
Kinetics of FGFR3 promoter chromatin remodeling
The kinetics of chromatin remodeling was next monitored.
C3H10T1/2 cells were treated with BMP-2 for the indi-
cated periods of time followed by restriction enzyme
hypersensitivity analysis. An increase in nuclease accessi-
bility was observed with ApaL I digestion as early as
15min and became evident 30min after BMP-2 addition.
The high level of chromatin accessibility was sustained for
the duration of the assay (Figure 6A). It was noticeable
that chromatin remodeling slightly preceded the increase
in FGFR3 mRNA (Figure 1B), suggesting that chromatin
remodeling is a primary event in the transcriptional acti-
vation of FGFR3 gene expression.
As BMP-2-induced immediate FGFR3 expression is
independent of protein synthesis, we further analyzed
the requirement for new protein synthesis in nucleosome
remodeling. After pretreatment of C3H10T1/2 cells with
the translation inhibitor CHX for 30min before BMP-2
addition, the increase in restriction enzyme cleavage
remained unchanged (Figure 6B). These results indicate
that, new protein synthesis is not necessary for either
FGFR3 transcription (Figure 1C) or for BMP-2-elicited
chromatin remodeling at the FGFR3 promoter.
As shown in Figure 1, p38 MAPK is necessary for
BMP-induced FGFR3 gene expression in C3H10T1/2
cells. To determine whether the inhibition of the p38
MAPK pathway has any eﬀect on BMP-2-elicited nucleo-
some remodeling across the FGFR3 promoter, C3H10T1/
2 cells were pretreated with SB203580 before stimulation
with BMP-2 and subsequent digestion with ApaL I. The
inhibition of the p38 MAPK pathway signiﬁcantly abro-
gated the increase in restriction enzyme cleavage by BMP-
2 (Figure 6B), indicating that the activation of the p38
pathway is essential for chromatin remodeling by BMP-2.
Changes in the accessibility of nucleosome-packaged
DNA can be mediated by the SWI–SNF remodeling
complex. To investigate whether the core SWI–SNF com-
ponent Brg1 associates with the FGFR3 promoter during
BMP-2-induced diﬀerentiation, ChIP was used. Two
regions of the FGFR3 gene were evaluated by real-time
PCR in order to determine the binding of the remodeling
complex: the +1 region corresponding to both the
transcription start site and the BMP-2-induced nuclease
hypersensitive site, and the –3kb region as a control
(Figure 8A). Brg1 was observed at the +1 region as
early as 15min after BMP-2 addition, with peak detection
occurring at 30min, after which it began to decline but
was still above the basal level 24h after BMP-2 addition
Figure 4. Mapping of the BMP-2-induced DNase I hypersensitivity within the proximal FGFR3 promoter. C3H10T1/2 cells were treated with or
without 200ng/ml BMP-2 with 5% FBS for 1day. Nuclei were then puriﬁed and digested with increasing concentrations of DNase I (0, 1, 3, 5U/ml)
and DNA was puriﬁed and cleaved with Nco I. After Southern blotting, the ﬁlter was hybridized with the
32P-labeled probe used in the MNase
digestion assay. The DNase I-hypersensitive sites are indicated by arrowheads. As a control, puriﬁed genomic DNA from C3H10T1/2 cells was
digested in vitro with increasing concentrations of DNase I. Size markers were generated as described in ‘Material and Methods’ section.
The diagrams at the right of each panel indicate the positions of the transcription start site and the probes used for hybridization (solid bars).
The large signal near +1 in the ﬁgure on the left is an autoradiograph artifact.
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complex was undetectable at the –3kb region. These
results suggest that the SWI–SNF remodeling complex
may contribute to BMP-2-induced nucleosome remodel-
ing at the FGFR3 promoter. Following on from the
results shown in Figure 6B, we studied whether phosphor-
ylation of p38 is responsible for the recruitment of the
remodeling complex to the proximal promoter using the
ChIP assay, and the resulting data demonstrated that
SB203580 did indeed signiﬁcantly inhibit binding of
Brg1 to the FGFR3 promoter (Figure 6D).
BMP-2-induced binding of Sp1 to the nuclease
hypersensitive site
The existence of a nuclease hypersensitive site strongly
indicates the binding of transcription factors as
Figure 5. Alteration in the restriction enzyme accessibility at the FGFR3 proximal promoter induced by BMP-2 treatment. (A) C3H10T1/2 cells were
incubated in the presence or absence of 200ng/ml BMP-2 with 5% FBS for 1day. Nuclei were then puriﬁed and digested with 25–200U of restriction
enzyme/ml, and puriﬁed DNA was digested to completion with Nco I. Products were detected by Southern blotting (top panel). A tentative
assignment of the nucleosome positions in this region based on nuclease digestion is shown and is aligned with the nuclease-hypersensitive sites.
Sites of cutting by DNase I and MNase and restriction enzyme are depicted by solid bars for basal conditions. Because MNase preferentially digests
DNA in linker regions between nucleosomes, it is possible to locate nucleosomes within the FGFR3 proximal promoter. Hollow arrow heads indicate
increases in the nuclease hypersensitivity upon BMP-2 exposure. (B) The relative nuclease sensitivity of restriction enzyme sites was quantitated, and
the intensities of the radioactive bands were used to calculate the percentage of DNA digested. All the results are the means of three independent
experiments standard deviation.  P<0.05 versus the untreated control cells.
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potential role of the cis elements at this region. A search
for transcription factor-binding sites using an online soft-
ware program (MatInspector, http://www. genomatix.de/
online_help/help_matinspector/matinspector_help.html)
revealed four Sp1-binding sites immediately upstream of
the transcription start site (Figure 7A). We found that,
among the four Sp1 sites, Sp1-1 overlapped with the
NHS under basal conditions, whereas Sp1-2, Sp1-3 and
Sp1-4 were located in the BMP-2-induced NHS
(Figure 7B bottom panel).
So, we determined the regulatory roles of these
Sp1-binding sites by constructing a luciferase reporter
containing the DNA fragment from the region spanning
–224 to +10 (pGLP). After transient transfection of the
reporter construct into C3H10T1/2 cells in the presence or
absence of 200ng/ml BMP-2, luciferase activities were
determined. About a 30-fold increase in luciferase activity
was observed with the –224/+10 fragment as compared
with the control vector pGL3 (Figure 7B) in untreated
cells. In order to verify the contribution of each
Sp1-binding site to the overall activation, we generated
mutant reporter plasmids in which the Sp1-binding sites
were mutated by inserting the EcoR I restriction site GAA
TTC. Upon transient transfection into C3H10T1/2 cells,
luciferase activities were determined, and it was found that
mutation of the Sp1 sites suppressed the basal activity by
53% (Sp1-1), 55% (Sp1-2), 39% (Sp1-3) and 35% (Sp1-4)
as compared with the wild-type construct (Figure 7B).
These data indicate that all the Sp1-binding sites con-
tribute to the basal promoter activity. Surprisingly, no
apparent inducible activity by BMP-2 treatment was
detected in any of the constructs. As a positive control,
three tandem repeats of a standard BMP-2 responsive ele-
ment (BMPRE) (GCCGCGCCGGCTCCAGGGCAGG
AGCGGC) were inserted into the multiple cloning sites
upstream of a core promoter and the luciferase gene in a
pGL3-promoter vector (pGL3BMRE). Smad1 and Smad5
directly bound to the BMPRE and stimulated its transac-
tivity. After transient transfection into C3H10T1/2
followed by BMP-2 induction for 24h, the expression
level of luciferase increased signiﬁcantly as compared
with that of untreated cells, suggesting that our system
works well.
The interaction between Sp1 and the FGFR3 core pro-
moter in vivo was subsequently determined by ChIP ana-
lysis using the antibody against Sp1. Although the
distance between the Sp1-1 and Sp1-4 sites is smaller
than the average chromatin fragments produced during
sonication (300–1000bp), and no suitable primer is avail-
able to discriminate the binding of Sp1 protein to diﬀerent
binding sites, primers correlating with the +1 region were
used to detect Sp1 binding to all the sites. Additionally,
the –3k region and another two primer sets were used for
real-time PCR in order to evaluate the results of the ChIP:
+6k corresponds to an area in the third exon; the 30
region is a part of the 30UTR contained in the last exon
(Figure 8A). As shown in Figure 8B, in untreated
C3H10T1/2 cells, Sp1 protein is present at the +1
region, strongly suggesting its role in regulating basal
transcription of FGFR3. In contrast with the results of
the luciferase reporter assay (Figure 7B), the ChIP results
showed that 30min after BMP-2 induction, binding of
Sp1 protein began to increase with the peak level reached
at 60min, and remained stably bound to the promoter
(Figure 8B).
Collectively, our data suggest a possible mechanism
whereby Sp1 regulates FGFR3 expression: under basal
conditions, the Sp1-1 site is highly accessible to Sp1 pro-
tein, resulting in basal transcription; upon BMP-2 treat-
ment, the nucleosome occupying the +1 region is
removed, thus exposing the previously masked Sp1-2, 3
and 4 sites, and the initiation site; more Sp1 proteins are
recruited to the core promoter, leading to the upregulation
of FGFR3 expression level.
Ordered recruitment of histone acetyltransferase and basal
transcription factors to the FGFR3 core promoter in vivo
As the removal of the nuc +1 from the chromatin exposed
the TSS, we performed a ChIP assay to conﬁrm BMP-
2-enhanced recruitment of RNA polymerase II to the
start site. Consistent with the kinetics of FGFR3 tran-
scription, RNA polymerase was observed under basal
Figure 6. Kinetics of FGFR3 gene chromatin remodeling in C3H10T1/
2. (A, B) C3H10T1/2 cells were incubated with 200ng/ml BMP-2 with
5% FBS for the indicated periods of time (A), or pretreated with
SB203580 (10mM) and CHX (10mM) respectively for 30min, then cul-
tured for 1day in the presence of BMP-2 (200ng/ml) (B). Nuclei were
then puriﬁed and digested with 80U of ApaL I, and puriﬁed DNA was
digested to completion with Nco I. Products were detected by Southern
blotting. (C) Chromatin from C3H10T1/2 was harvested 0, 5, 15, 30,
60, 120min and 24h after stimulation with 200ng/ml BMP-2. The
chromatin was precipitated with anti-Brg1 antibodies. After DNA
recovery, the precipitates were evaluated by real-time PCR for the
level of enrichment over the negative control antibody with the primers
shown in Figure 8A. All the results are the means of three independent
experiments   standard deviation. (D) C3H10T1/2 cells were pretreated
with control or SB203580 (10mM) for 30min and cultured for another
30min in the presence or absence of BMP-2 (200ng/ml). The chromatin
was precipitated with anti-Brg1 antibodies, and the +1 region (shown
in Figure 8A) was examined for binding of Brg1.
Nucleic Acids Research, 2009,Vol.37, No. 12 3905conditions, and enrichment began to increase 30min after
BMP-2 treatment, peaking at 1h, and was maintained at
a high level throughout the remaining period, although
a moderate decrease was detected. Association of Pol II
appeared to be maximal in the +1 and +6kb regions and
undetectable in the –3kb region at any point (Figure 8C).
It has been previously reported that the HAT p300
enzyme binds Sp1 target promoters, and that its binding
correlates with the presence of highly acetylated histones
(21). From the results obtained thus far, we hypothesized
that BMP-enhanced Sp1 binding by remodeling of
the nucleosome might control the transcription of the
FGFR3 gene through local recruitment of histone-
modifying enzymes. Therefore, we performed experiments
to verify whether Sp1 might recruit the p300 enzyme
onto FGFR3 promoter sequences and consequently
allow speciﬁc recruitment of acetylated histones. The
ChIP results showed that p300 is present in the +1
region of the FGFR3 gene in untreated C3H10T1/2 cells
(Figure 8D). An increase was observed only 30min after
BMP-2 induction, and at the same time, BMP-2 enhanced
the binding of Sp1 to the same region in vivo (Figure 8D
and 7B). Additionally, p300 and Sp1 shared a similar
kinetic pattern of FGFR3 promoter association, indicat-
ing the local recruitment of p300 by Sp1 protein under
both basal and BMP-2-induced conditions.
Next, we performed a Re-ChIP assay in order to
conﬁrm whether Sp1 and p300 are co-recruited onto the
proximal promoter. In Re-ChIP analysis, we immunopre-
cipitated the Sp1- or p300-containing complexes with
Figure 7. Sp1-binding sites contribute to the basal activation of the FGFR3 gene promoter. (A) Location of putative Sp1-binding sites in the FGFR3
proximal promoter. (B) Transient transfection of C3H10T1/2 in the presence or absence of BMP-2 (200ng/ml) with 5% FBS for 24h was used
to determine the transcriptional activity of chimeric construct pGLP, which included nts –224 and +10, as well as a series of 6-bp substitutions
that were made within the context of pGLP (right panel). The diagram shows the structure of the FGFR3 promoter construct: the four putative
Sp1-binding sites are indicated by circles; mutated Sp1 sites are shown as black circles (left panel). As a positive control, pGL3BMPRE was
transiently transfected into C3H10T1/2 in the presence or absence of BMP-2 (200ng/ml) for 24h, followed by determination of luciferase activity
(C). All the results are the means of three independent experiments standard deviation.
3906 Nucleic Acids Research, 2009, Vol. 37,No. 12antibodies against p300 or Sp1, respectively, and only
those DNA sequences that are simultaneously bound by
both proteins would be ampliﬁed in the subsequent PCR.
Our results showed that p300 and Sp1 were co-recruited
on the same DNA fragments (Figure 8E), suggesting that
the two factors co-occupy common target loci. These
results strongly support a direct role of Sp1 in p300
recruitment to the FGFR3 promoter, leading to the acti-
vation of epigenetic markers at the same location, as
described in the next paragraph.
Dynamics of histone modifications at the FGFR3 gene
Acetylation has long been known to be associated with
actively transcribed genes and open chromatin conﬁgura-
tions. Antibodies speciﬁc to diacetylated H3 (K9 and K14)
and tetraacetylated H4 (K5, K8, K12 and K16) were used
in ChIP analysis to determine the pattern of histone mod-
iﬁcation upon BMP-2 exposure. In untreated cells, both
H3 and H4 were acetylated at all the testing areas, with the
lowest level in the 30 extreme region. Upon treatment,
histone acetylation began to modestly increase at 15min
post-induction and reached a high level at 30min, which
was sustained throughout the remaining time (Figure 9A
and B). Interestingly, the histone acetylation was prefer-
entially restricted to the 50 region of the gene, whereas the
30 extreme region showed a small induction of acetylation.
As for histone methylation, trimethylH3K4 (a euchro-
matic marker) was not apparently scored under basal con-
ditions, and increased somewhat slowly, reaching a peak
at 1day (Figure 9C). As for the heterochromatin marker
dimethylH3K9, which serves as a signal for chromatin
silencing by recruiting the HP1 protein (heterochromatin
protein 1) and is mutually exclusive with H3–K9 acetyla-
tion, it was measurable before BMP-2 treatment, then
began to drop slowly and moderately to background
levels at 24h (Figure 9D). Taken together, these results
indicate that transcription activation of FGFR3 is
correlated with an increase in the local recruitment of
euchromatic markers and a decrease in that of the hetero-
chromatic marker.
Figure 8. Coactivator recruitment to the FGFR3 promoter. (A) The locations of the real-time PCR primer sets used for ChIP assays are shown (B, C
and D). Chromatin from C3H10T1/2 cells was harvested 0, 5, 15, 30, 60, 120min and 24h after stimulation with 200ng/ml BMP-2 with 5% FBS and
precipitated with anti-Sp1 (B), anti-Pol II (C), and anti-p300 (D) antibodies. After DNA recovery, the precipitates were evaluated by real-time PCR
for the level of enrichment over the negative control antibody. All the results are the means of three independent experiments standard deviation.
(E) ChIP and Re-ChIP experiments performed with anti-Sp1 and anti-p300 antibodies on C3H10T1/2 cells with 200ng/ml BMP-2 for 24h.
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In our study, we ﬁrst identiﬁed the mechanism by which
BMP-2 regulates the expression of FGFR3. The novel
insight provided is 3-fold: ﬁrst, Sp1-binding sites contrib-
ute to both the basal and BMP-2-enhanced activation of
the FGFR3 promoter in C3H10T1/2 cells; second, BMP-
2-induced dynamic alteration of nucleosome positioning
in the proximal promoter was determined and third, the
ordered recruitment of various nuclear factors and the
covalent modiﬁcation of histones in the FGFR3 promoter
in response to BMP-2 treatment were examined in detail.
By comparing the timing of recruitment of Brg1, Sp1,
p300 and Pol II with histone modiﬁcation and chromatin
remodeling, we are able to provide a nearly complete pic-
ture of the molecular mechanism that determines BMP-
2-induced FGFR3 expression. Under basal conditions,
several nucleosomes are found in the promoter, except in
an area localized in the linker region between Nuc–1 and
Nuc+1. The association of Sp1 protein with its binding
site (Sp1-1) contained in this nucleosome-free region may
result in the recruitment of histone acetyltransferases
(such as p300) to the promoter, leading to basal acetyla-
tion of the histone tail and maintaining the open conﬁgu-
ration of the local chromatin. Furthermore, such events
occurring at the proximal promoter provide chromatin
accessibility to polymerase II to initiate the transcription
of the FGFR3 gene in a persistent manner, although at
a relatively low level.
Upon BMP-2 treatment, the SWI/SNF complex was
ﬁrst found to be associated speciﬁcally with the proximal
promoter region after only 15min of induction. Although
such binding is in a transient manner—reaching a peak at
30min, then declining quickly—it is suﬃcient to yield a
state of open conﬁguration of the local chromatin through
releasing Nuc+1 from the transcription start site. This
primes for a rapid increase in the FGFR3 transcription
level by exposing the Sp1-binding sites (Sp1-2, Sp1-3 and
Sp1-4). An increase in Sp1 binding to the promoter
is apparent at 30min after BMP-2 treatment, and it can
further recruit p300. The putative p300 and Sp1 complex
may upregulate the H3 and H4 acetylation levels that
are responsible for the initiation and maintenance of
enhanced local chromatin accessibility to the general tran-
scription apparatus, upregulating the FGFR3 expression
level.
SWI/SNF complexes have been shown to have impor-
tant functions in development and diﬀerentiation in many
tissues, organs and cells (22), but their functions in osteo-
genic or chondrogenic diﬀerentiation are not well under-
stood. In a previous study (23), the expression of several
components of the SWI/SNF complex was reported to
be upregulated during BMP-2-mediated osteogenesis
in C2C12 cells. These ﬁndings also demonstrate that
Figure 9. Changes in histone acetylation and methylation upon BMP-2 treatment. Kinetic ChIP analysis of C3H10T1/2 cells as in Figure 8, with
antibodies directed against diacetyl–H3 (A), tetra–acetyl–H4 (B), trimethyl–H3–K4 (C) and dimethyl–H3–K9 (D). The results shown are expressed as
enrichment over the negative control antibody. All the results are the means of three independent experiments standard deviation.
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Runx2-dependent skeletal genes requires SWI/SNF com-
plexes. In another work (24), Villagra et al. reported that
transcription of osteocalcin (a bone-speciﬁc gene that is
expressed in the late stages of osteoblastic diﬀerentiation)
involves an active chromatin-remodeling process mediated
by ATP-dependent SWI/SNF activity that is speciﬁcally
recruited to the proximal promoter region. In our study,
we found that BMP-2 is capable of increasing the binding
of the remodeling complex to the FGFR3 promoter in
C3H10T1/2 cells. This recruitment of the SWI/SNF com-
plex is a rapid response to BMP-2 induction, beginning at
15min and reaching a peak at 30min, consistent with the
fast kinetics of FGFR3 expression upon induction
(Figure 6C). But the mechanism whereby BMP-2 plays
its role in this process remains to be elucidated. Our
data suggest that at least two features may ensure the
rapid recruitment of the remodeling complex. First, diﬀer-
ent from the study reported by Yong et al. (23), BMP-
2-induced binding of the complex is independent of the
upregulation of the expression level of the remodeling
complex or other proteins, as this process is insensitive
to CHX treatment. Second, it is well established that
acetylated chromatin is the preferred substrate for SWI/
SNF recruitment. Brg1 bears a bromodomain, which can
interact with acetylated histone N-termini, suggesting that
histone acetylation provides a higher-aﬃnity surface
for interaction with the SWI/SNF complex, thus leading
to more stable nucleosomal binding. Under basal condi-
tions, histones surrounding the proximal promoter of the
FGFR3 gene are acetylated to a certain degree. We believe
that basal acetylation may ‘pre-activate’ the histones to be
ready for binding the remodeling complex, enabling the
rapid binding of the SWI/SNF complex to the promoter,
shortening the time taken to react to BMP-2 induction.
Another key issue is how the SWI/SNF complex is tar-
geted to the speciﬁc promoter. Our results demonstrate
that recruitment of the complex is dependent on p38 acti-
vation (inhibited by SB203580), which can phosphorylate
several downstream targets (Figure 1D, 6B and D). The
simplest possibility is that activated p38 may phosphory-
late a sequence-speciﬁc transcription factor required for
the cooperative recruitment of the SWI/SNF complex to
the FGFR3 proximal promoter. SWI/SNF components
have been shown to interact with several transcriptional
activators, including nuclear steroid receptors (25), human
heat shock factor 1 (26), EKLF (27), c-Myc (28), C/EBPb
(29) and C/EBPa (30); however, only a few transcription
factors have been demonstrated to target the SWI/SNF
complex to speciﬁc cellular promoters (31,32). We do
not think that Sp1 is the candidate transcription factor,
as BMP-2-induced Sp1 recruitment is preceded by Brg1
recruitment; however, the binding sites for other transcrip-
tion factors not yet identiﬁed in the FGFR3 promoter
region may contribute to BMP/p38-dependent recruit-
ment of a partner of the SWI/SNF complex.
Interestingly, the remodeling complex is recruited to
the promoter in a transient way, beginning at 15min
and decreasing to nearly background levels; in contrast,
the BMP-2-induced FGFR3 transcription level may be
maintained for at least 6 days (data not shown). So, we
conclude that once the nucleosome has been removed
from the proximal promoter, the remodeling complex is
no longer required. Instead, other mechanisms such as
chromatin modiﬁcation may be responsible for maintain-
ing the local chromatin accessibility. We observed an
increase in the local recruitment of euchromatic markers
and a decrease in that of the heterochromatic marker.
The acetylation of the histone tails disrupts and interferes
with the higher order chromatin folding, promotes the
solubility of chromatin at physiological ionic strength
and maintains the unfolded structure of the transcribed
nucleosome, allowing transcription factor binding
(33,34). At 30min after BMP-2 induction, dramatic
increases in H3 and H4 acetylation level, as well as Sp1
and p300 recruitment, were observed, indicating the pos-
sibility that p300 is responsible for histone acetylation
(Figure 7B, 9A and B). The increase in trimethylation
of H3-K4 (an euchromatic marker) lagged behind that
of histone acetylation, reaching the peak level at 1day
(Figure 9C). We believe that this slow dynamic pattern
may partially compensate for the decrease in H3 and H4
acetylation level at a late stage to maintain the unfolded
chromatin structure.
In our experiment performed in order to analyze histone
modiﬁcation, two points should be noted:
(i) Histone acetylation began to increase modestly at
15min post-induction, preceding the recruitment of
p300, suggesting that histone acetylation, at least at
the early stage, is independent of p300. A previous
report (35) indicated that p38 MAPK, which is
strongly activated by LPS, is responsible for the
phosphoacetylation of histone H3 on promoters of
a subset of stimulus-induced cytokine and chemo-
kine genes by enhancing the accessibility of the
NF-kB-binding sites. So, we hypothesized that acti-
vation of the BMP/p38 pathway could improve the
local histone acetylation level, which may facilitate
the binding of the SWI/SNF complex, as discussed
above. Our further study will focus on the relation-
ships between p38, the SWI/SNF complex and his-
tone acetylation at the FGFR3 proximal promoter
region.
(ii) The +1 region that we expected to be the most
prominent area in histone modiﬁcation showed
only modest alteration, and the strongest positivity
was found in the +6k region. This is surprising, as
the +1 region was where the remodeling complex,
as well as Sp1 and p300, bound to chromatin
and contributed most to the promoter activity.
One important possibility cannot be ruled out:
BMP-2-induced depletion of Nuc+1 from the +1
region may be responsible for the decreased level of
histone modiﬁcation, as previously reported (36,37).
The nuclear coactivator p300 is a transcriptional adaptor
for many DNA-binding activators; it possesses intrinsic
acetyltransferase activity, which, by chemically modifying
histone tails, aﬀects the nucleosomal environment and
transcription (38). The general transcription factor Sp1,
which binds and interacts with GC boxes in the promoter
Nucleic Acids Research, 2009,Vol.37, No. 12 3909regions of target genes, is capable of activating the tran-
scription of some genes. It has previously been reported
the Sp1 and p300 cooperate to transactivate the expression
of the embryonic globin gene (39), 12(s)-lipoxygenase (21),
p21 (40) and TbRII (41). Hung et al. reported that Sp1
physically interacts with p300, and recruits p300 to the
target promoter, leading to a chromatin modiﬁcation
that induces the transcription activity of the 12(s)-lipoxy-
genase gene (21); Suzuki et al. demonstrated physical and
functional interaction between the acetyltransferase region
of p300 and the DNA-binding domain (DBD) of the tran-
scription factor Sp1 (42); and in another work, p300 was
found to indirectly interact with Sp1 through progesterone
receptors (43). In our study, the ChIP results demon-
strated that p300 and Sp1 share a similar kinetic pattern
of FGFR3 promoter association, and both are
co-recruited on the same DNA fragments, strongly sup-
porting a direct role of Sp1 in p300 recruitment to the
FGFR3 promoter. However, is it the case that p300
directly interacts with Sp1, or that they indirectly interact
through a common multi-protein complex? Further study
is needed in order to gain a detailed picture of the coop-
eration of p300 and Sp1 uncovered in our study.
Furthermore, apart from its HAT activity, the p300
protein may act as a bridging factor to connect
sequence-speciﬁc transcription factors to the basal tran-
scription machinery (41). Sp1 is also known to interact
with the N terminus of the TATA-binding protein-
associated factor dTAF110 in the TFIID complex, and
this interaction may account for the ability of Sp1 to
assemble the pre-initiation complex to activate tran-
scription from TATA-less promoters (44). Therefore, we
believe that both Sp1 and p300 are responsible for the
recruitment of Pol II to the FGFR3 promoter to activate
its expression under basal and BMP2-induced conditions.
In this study, when we conﬁned the BMP-2-upregulated
nuclease hypersensitive site to a more precise region, a
conventional method, luciferase reporter assay, was used
to delineate the promoter: after construction and transient
transfection of the luciferase reporter containing the prox-
imal promoter, the reporter plasmids showed the proper
basal promoter function, but exhibited no inducible activ-
ity upon BMP-2 treatment. We think that, unlike stably
transfected plasmids or episomal constructs, the chroma-
tin structure of transiently transfected plasmids is usually
incomplete or aberrant, and may vary with cell type and
the transfection method used. We postulate that in our
transient transfection experiment, the proximal promoter
region had not been packaged into a chromatin-like struc-
ture, and may even have been in a ‘naked’ state, and as
a result, Sp1-2, 3 and 4-binding sites and the TSS may
not have been occupied by nucleosomes, leading to high
accessibility to various nuclear factors, including the basal
transcription apparatus. Hence, BMP-2 induction cannot
exert its regulatory role through remodeling the chromatin
structure, and upregulated promoter activity was unde-
tectable in our luciferase reporter assay. Therefore, it is
important that the promoter activity is studied in its native
chromatin context.
In conclusion, in this work we demonstrated that BMP-2
upregulates the FGFR3 expression level by controlling the
local chromatin structure through the recruitment of the
remodeling complex, which in turn initiates a cascade of
molecular events to increase the chromatin accessibility for
the general transcription apparatus.
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